Summary: No probiotic supplement is licensed in the UK to modulate GLP-1 or treat obesity, and current evidence does not support their use as effective weight loss interventions
With increased sample size, this work can be the catalysis toward prompting personalized instructions and specifications for improved use of topical sprays
Clinical evidenceparticularly for -lipoic acid, curcumin, green tea, vitamin B12, melatonin, and CoQ10supports symptomatic relief and functional improvement, although trials remain small and heterogeneous
The company's current research pipeline includes: How to obtain the latest research advancements in the field of biopharmaceuticals
Luo T, Zhang S-G, Zhu L-F, Zhang F-X, Li W, Zhao K, et al